Parallel synthesis of 9-aminoacridines and their evaluation against chloroquine-resistant Plasmodium falciparum
- PMID: 16216519
- PMCID: PMC1474025
- DOI: 10.1016/j.bmc.2005.08.017
Parallel synthesis of 9-aminoacridines and their evaluation against chloroquine-resistant Plasmodium falciparum
Abstract
A parallel synthetic strategy to the 9-aminoacridine scaffold of the classical anti-malarial drug quinacrine (2) is presented. The method features a new route to 9-chloroacridines that utilizes triflates of salicylic acid derivatives, which are commercially available in a variety of substitution patterns. The route allows ready variation of the two diversity elements present in this class of molecules: the tricyclic aromatic heterocyclic core, and the disubstituted diamine sidechain. In this study, a library of 175 compounds was designed, although only 93 of the final products had purities acceptable for screening. Impurity was generally due to incomplete removal of 9-acridones (18), a degradation product of the 9-chloroacridine synthetic intermediates. The library was screened against two strains of Plasmodium falciparum, including a model of the drug-resistant parasite, and six novel compounds were found to have IC(50) values in the low nanomolar range.
Figures
References
-
- Sachs J, Malaney P. Nature. 2002;415:680–5. - PubMed
-
- Kitron U, Spielman A. Rev. Infect. Dis. 1989;11:391–406. - PubMed
-
- Gilles HM. Management of Severe Malaria: A Practical Handbook. 2nd ed. World Health Organization; Geneva: 2000.
-
- Ridley RG. Nature. 2002;415:686–93. - PubMed
-
- Foley M, Tilley L. Pharmacol. Ther. 1998;79:55–87. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
